Automated JTpeak analysis by BRAVO

J Electrocardiol. 2017 Nov-Dec;50(6):752-757. doi: 10.1016/j.jelectrocard.2017.07.010. Epub 2017 Jul 14.

Abstract

Using BRAVO algorithm (AMPS-LLC, NY, v4.4.0), 5223 ECGs from a publicly available annotated dataset from a randomized clinical trial on four different compounds and placebo were analyzed. ECGs were automatically processed and JTp interval was computed on: 12 standard ECG leads, Vector Magnitude (VM), and root mean square (RMS) leads. On VM and RMS, JTp intervals were nearly identical (228 ± 29 vs. 227 ± 30 ms respectively, with correlation of 0.99, p < 0.0001). On lead II, JTp interval was about 10 ms longer, but highly correlated with that measured on VM (0.94, p < 0.0001). Similarly, on lead V5, JTp was about 8 ms longer than on VM, with a correlation of 0.95, p < 0.0001. When compared to the public available annotations, JTp by BRAVO generated longer (about 8 ms) measurement and evidenced outliers conducible to both the T-wave peak (in few ECGs presenting notched shapes) and, to a lesser degree, to the J point, due to variability of the two algorithms. Differences on the drug-induced effect from the four compounds were negligible.

Keywords: Automatic algorithm; ISCE; JTp; PhysioNet; T-wave morphology; T-wave peak.

MeSH terms

  • Algorithms*
  • Diagnosis, Computer-Assisted*
  • Electrocardiography, Ambulatory / methods*
  • Heart Conduction System / drug effects*
  • Humans
  • Phenethylamines / pharmacology
  • Potassium Channel Blockers / pharmacology*
  • Quinidine / pharmacology
  • Randomized Controlled Trials as Topic
  • Ranolazine / pharmacology
  • Sodium Channel Blockers / pharmacology*
  • Software
  • Sulfonamides / pharmacology
  • Verapamil / pharmacology

Substances

  • Phenethylamines
  • Potassium Channel Blockers
  • Sodium Channel Blockers
  • Sulfonamides
  • Ranolazine
  • Verapamil
  • Quinidine
  • dofetilide